Treatment of diabetes with thiazolidinedione and sulphonylurea (glibenclamide, glipizide, gliclazide, glimepiride, tolazamide and tolbutamide

摘要

A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser; 5-[4-[2-N(N-methyl-(2-pyridyl)amino)-ethoxy]benzyl]thiazolidine-2,4-dione and an insulin secretagogue, to a mammal in need thereof.